EUVIMEDEUVIMED entdecken
Crossref

Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials

Ben Wijnen, Filip Smit, Ana Ivičević Uhernik, Ana Žegrec, Jovo Dedovic, Roumyana Dinolova, Raluca Nica, Aleksander Tomcuk, Robert Velickovski, Michel Wensing, Laura Shields-Zeeman, Ionela Petrea

The European Journal of Health Economics · 03.07.2026

DOI: 10.1007/s10198-026-01960-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, online erschienen am 03.07.2026. Verfasst von Ben Wijnen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Economic Evaluation, Trimbos Institute (Netherlands Institute of Mental Health and Addiction), P.O. Box 725, Utrecht, 3500 AS, The Netherla…. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The RECOVER-E project supported the shift away from mental health care provided in institutional settings (treatment as usual, TAU) towards community-based mental healthcare by introducing multidisciplinary community mental health teams (CMHT) for people with schizophrenia, bipolar disorder, and severe depression across five sites in Bulgaria, Croatia, Montenegro, North Macedonia, and Romania. This paper presents the cost-effectiveness of CMHT compared to TAU. METHODS: Data from all five RECOVER-E trials (N = 931) was used to compute healthcare costs and societal costs which included additional patient and family costs, and costs stemming from productivity losses. Outcomes were incremental cost-effectiveness ratio's (ICER) for gaining a QALY and gaining a treatment responder (based on WHODAS 2.0). RESULTS: Compared to TAU, CMHT had small incremental effects favouring CMHT (QALY: M = 0·023, SD = 0·013; Response: M = 0·093, SD = 0·034). The incremental costs were higher in CMHT than in TAU as seen from both the societal and healthcare perspective (societal costs: M=€1,892, SD=€950; healthcare costs: M = 1,125, SD=€720). The ICER for gaining a QALY was €82,261 and €48,913 as seen from the societal and healthcare perspective, respectively. These ICERs were well above the willingness to pay threshold of €20,000 for gaining a QALY. A similar picture arose with treatment response as outcome. CONCLUSION: Overall CMHT appeared to be more effective but also more costly, with the additional cost outweighing the benefits across countries, except in Bulgaria, which may highlight that cost-effectiveness is likely to be context dependent. Therefore, a recommendation for scaling up or sustaining CMHT must also depend on arguments other than health-economic alone, such as medical ethical, equity and human rights considerations. TRIAL REGISTRATION: Bulgaria: NCT03922425, Croatia: NCT03862209, Macedonia: NCT03892473, Montenegro: NCT03837340, Romania NCT03884933.

Schlagwörter

Stichwörter der Autor:innen

Bipolar disorderBulgariaCommunity mental healthcareCroatiaMontenegroNorth MacedoniaRomaniaSchizophreniaSevere major depression

Autor:innen und Institutionen

  • Centre of Economic Evaluation, Trimbos Institute (Netherlands Institute of Mental Health and Addiction), P.O. Box 725, Utrecht, 3500 AS, The Netherlands. bwijnen@trimbos.nl.
  • Centre of Economic Evaluation, Trimbos Institute (Netherlands Institute of Mental Health and Addiction), P.O. Box 725, Utrecht, 3500 AS, The Netherlands.
  • Department of Biostatistics and Epidemiology, Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Division of Public Health, Croatian Institute of Public Health, Zagreb, Croatia.
  • Division for School Medicine, Mental Health and Addiction Prevention, Croatian Institute of Public Health, Zagreb, Croatia.
  • Special Psychiatric Hospital Dobrota, Kotor, Montenegro.

Förderung

  • Horizon 2020 Framework Programme

Zitieren

APA

Wijnen, B., Smit, F., Uhernik, A. I., Žegrec, A., Dedovic, J., Dinolova, R., Nica, R., Tomcuk, A., Velickovski, R., Wensing, M., Shields-Zeeman, L., & Petrea, I. (2026). Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials. The European Journal of Health Economics. https://doi.org/10.1007/s10198-026-01960-1

Vancouver

Wijnen B, Smit F, Uhernik AI, Žegrec A, Dedovic J, Dinolova R, et al. Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials. The European Journal of Health Economics. 2026. doi:10.1007/s10198-026-01960-1

BibTeX
@article{Wijnen2026,
  author = {Wijnen, Ben and Smit, Filip and Uhernik, Ana Ivičević and Žegrec, Ana and Dedovic, Jovo and Dinolova, Roumyana and Nica, Raluca and Tomcuk, Aleksander and Velickovski, Robert and Wensing, Michel and Shields-Zeeman, Laura and Petrea, Ionela},
  title = {Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials},
  journal = {The European Journal of Health Economics},
  year = {2026},
  doi = {10.1007/s10198-026-01960-1}
}
Kostenlos starten →